Journal Watch · Circulation · 2026

Outcomes of Hypoplastic Left Heart Syndrome by Subtype and Presence of Ventriculocoronary Connections: A Fetal Heart Society Multicenter Retrospective Study.

This study underscores the prognostic value of assessing for VCCs in patients with HLHS both before and after birth.

Barris DM, Freud LR, Day PE et al.Circulation4 min readPharma relevance 65/100

DOI: 10.1161/circulationaha.126.080144PMID: 42934200Study type: cohort / observational clinical study

TL;DR

This study underscores the prognostic value of assessing for VCCs in patients with HLHS both before and after birth.

Key findings

  • This was followed by MA/AA (HR, 1.40 [0.95, 2.05]; 5-year TFS, 54.1%; 10-year TFS, 46.6%).
  • Survival of MS/AA without VCCs (5-year TFS, 60.4%; 10-year TFS, 56.9%) was similar to MS/AS (HR, 0.91 [0.59, 1.41]; 5-year TFS, 65.0%; 10-year TFS, 58.3%).
  • Among those with a prenatal diagnosis of HLHS (n=532), patients with MS/AA and VCCs suspected on fetal echocardiogram had a lower TFS compared with those with MS/AA without fetal suspicion for VCCs (HR, 1.79 [1.12, 2.85]).
  • Fetal echocardiography was used to diagnose VCCs in 33 of 103 (32%) cases with MS/AA and VCCs suspected postnatally.
  • Of patients with MS/AA and VCCs, type of stage I palliation was not associated with TFS (<i>P</i>=0.784).<h4>Conclusions</h4>In a large, multicenter cohort of HLHS patients, the MS/AA subtype with VCCs had the lowest TFS.

Numbers at a glance (from the abstract)

n=53244%34%22%58%55.6%49.4%44.7%40.3%54.1%46.6%60.4%

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

Cox proportional hazards analysis was performed, controlling for cardiac center (random effect), birth weight, genetic diagnosis, extracardiac malformation, and restricted/intact atrial septum.<h4>Results</h4>Among 16 centers, 591 patients were born alive with intention to treat. MA/AA was the most common subtype (261, 44%), followed by MS/AA (200, 34%) and MS/AS (130, 22%). Of those with MS/AA, 115 (58%) had suspected VCCs. Median follow-up was 9.0 (interquartile range: 7.0, 10.8) years. Overall transplant-free survival (TFS) was 55.6% at 5 years and 49.4% at 10 years. When comparing MA/AA, MS/AS, and MS/AA with and without VCCs (reference group: MS/AA without VCCs), MS/AA with VCCs had the lowest TFS (hazard ratio [HR], 1.69 [1.12, 2.57]; 5-year TFS, 44.7%; 10-year TFS, 40.3%).

Full abstract (original)

Background: <h4>Background</h4>Hypoplastic left heart syndrome (HLHS) is classified by anatomic subtype: mitral atresia and aortic atresia (MA/AA), mitral stenosis and aortic atresia (MS/AA), and mitral stenosis and aortic stenosis (MS/AS). The MS/AA subtype is associated with ventriculocoronary connections (VCCs). We assessed whether specific HLHS subtypes are associated with an increased risk of mortality and whether this risk is stratified by VCCs identified during fetal or postnatal echocardiography. We also assessed whether the type of neonatal intervention performed modified the risk.<h4>Methods</h4>We performed a multicenter retrospective cohort study of fetuses and infants <2 months old with HLHS who were admitted between January 2012 and December 2016 to participating Fetal Heart Society institutions. Clinical and demographic data were collected. Fetal and transthoracic echocardiograms from a subset of patients with MS/AA and those with suspected VCCs were reviewed.

What they did: Cox proportional hazards analysis was performed, controlling for cardiac center (random effect), birth weight, genetic diagnosis, extracardiac malformation, and restricted/intact atrial septum.<h4>Results</h4>Among 16 centers, 591 patients were born alive with intention to treat. MA/AA was the most common subtype (261, 44%), followed by MS/AA (200, 34%) and MS/AS (130, 22%). Of those with MS/AA, 115 (58%) had suspected VCCs. Median follow-up was 9.0 (interquartile range: 7.0, 10.8) years. Overall transplant-free survival (TFS) was 55.6% at 5 years and 49.4% at 10 years. When comparing MA/AA, MS/AS, and MS/AA with and without VCCs (reference group: MS/AA without VCCs), MS/AA with VCCs had the lowest TFS (hazard ratio [HR], 1.69 [1.12, 2.57]; 5-year TFS, 44.7%; 10-year TFS, 40.3%).

Results & conclusions: This was followed by MA/AA (HR, 1.40 [0.95, 2.05]; 5-year TFS, 54.1%; 10-year TFS, 46.6%). Survival of MS/AA without VCCs (5-year TFS, 60.4%; 10-year TFS, 56.9%) was similar to MS/AS (HR, 0.91 [0.59, 1.41]; 5-year TFS, 65.0%; 10-year TFS, 58.3%). Among those with a prenatal diagnosis of HLHS (n=532), patients with MS/AA and VCCs suspected on fetal echocardiogram had a lower TFS compared with those with MS/AA without fetal suspicion for VCCs (HR, 1.79 [1.12, 2.85]). Fetal echocardiography was used to diagnose VCCs in 33 of 103 (32%) cases with MS/AA and VCCs suspected postnatally. Of patients with MS/AA and VCCs, type of stage I palliation was not associated with TFS (<i>P</i>=0.784).<h4>Conclusions</h4>In a large, multicenter cohort of HLHS patients, the MS/AA subtype with VCCs had the lowest TFS. Prenatal diagnosis of VCCs was associated with a lower TFS. This study underscores the prognostic value of assessing for VCCs in patients with HLHS both before and after birth.

Abstract © the authors / Circulation (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1161/circulationaha.126.080144 · PubMed 42934200.

Why it matters for pharma & biotech

  • Relevant to Pharmacology & Drug Discovery teams tracking Circulation for new targets, mechanisms and biomarkers.
  • Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.

Frequently asked questions

What did this Circulation study find?

This study underscores the prognostic value of assessing for VCCs in patients with HLHS both before and after birth.

What type of study is this?

It is a cohort / observational clinical study, published in Circulation in 2026. Cox proportional hazards analysis was performed, controlling for cardiac center (random effect), birth weight, genetic diagnosis, extracardiac malformation, and restricted/intact atrial septum.<h4>Results</h4>Among 16 centers, 591 patients were born alive with intention to treat.

Where can I read the original paper?

The original is at the publisher via DOI 10.1161/circulationaha.126.080144. PubMed ID: 42934200. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Barris DM, Freud LR, Day PE et al.. Outcomes of Hypoplastic Left Heart Syndrome by Subtype and Presence of Ventriculocoronary Connections: A Fetal Heart Society Multicenter Retrospective Study.. Circulation (2026). DOI: 10.1161/circulationaha.126.080144.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/outcomes-of-hypoplastic-left-heart-syndrome-by-subtype-and-presence-of-v-080144/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides